Gadopiclenol

N/A

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameGadopiclenol
Drug Alias NameEluciremVuewayG-03277P-03277
ClassificationDiagnostic agent (In vivo)Small molecules > Heterocyclic drugs
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsDiagnostic agentsVascular Diseases +[11
Global Approved IndicationsContrast agentsDiagnostic agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/09/21
Country/TerritoryCzechiaBelgiumCanada +[18
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGuerbet France
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsContrast agentsDiagnostic agentsVascular Diseases +[8
Inactive IndicationsBrain InjuriesLiver DiseasesCarcinoma, Hepatocellular

Other Information

ATC CodeV08CA12
Related LinksDrugBankKEGG